Welcome to the Villeneuve Lab
The Villeneuve Lab is interested in how the brain ages with a specific focus on the factors that modify the association between brain lesions and cognitive performances. Our research is motivated by the fact that more than 25% of older adults are considered cognitively normal despite the presence of beta-amyloid in their brain, a hallmark of Alzheimer’s disease. This fact suggests that other factors interact with beta-amyloid to trigger the expression of cognitive deficits in Alzheimer’s disease. It also suggests that actions can be taken to prevent or postpone the expression of disease-related symptoms. The main focus of The Villeneuve Lab’s research is therefore to examine the factors that protect (or worse) the development of cognitive deficits in age-related neurodegenerative diseases. We use a multi-tier approach that includes molecular PET imaging, MRI imaging, neuropsychological testing, and genetics.
Visit our research page to learn more about our ongoing projects.
Human Amyloid Imaging Conference 2018
17-19 Jan 2018
Dr. Villeneuve, along with Julie Gonneaud and Alexa Pichet Binette attended this year’s HAI conference in Miami to present some of their recent work. Julie gave a talk comparing sporadic AD and autosomal dominant AD, and Alexa presented her poster at the conference. [Photos]
New Article by Villeneuve Lab alumnus Sander Verfaillie
14 Dec 2017
A new article by Sander Verfaillie, “Subjective cognitive decline is associated with altered default mode network connectivity in individuals with a family history of Alzheimer’s Disease” published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging feature research on the subjective cognitive decline, brain connectivity pattern and family history of dementia.
Happy New Years! Our Lab Christmas Party 2017
7 Dec 2017
The Villeneuve Lab wishes everyone a happy new year! Photos
Human Amyloid Imaging Conference
2 Dec 2017
Congrats to Julie on receiving Human Amyloid Imaging conference travel fellowship to attend the conference that will be held on January 17-19, 2018 in Miami, FL.